Related Experiment Video
Updated: Dec 9, 2025

08:06
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
Published on: January 15, 2010
32.2K
Animal Model for Lower Urinary Tract Dysfunction in Parkinson's Disease
Takeya Kitta1, Mifuka Ouchi2, Hiroki Chiba1
1Department of Renal and Genitourinary Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido 060-8648, Japan.
International Journal of Molecular Sciences
|September 10, 2020
Summary
Parkinson's disease (PD) significantly impacts quality of life through non-motor symptoms like lower urinary tract dysfunction. This review examines animal models to understand and treat these urinary issues in PD patients.
Area of Science:
- Neuroscience
- Urology
Background:
- Parkinson's disease (PD) involves dopaminergic neuron loss, leading to motor and non-motor symptoms.
- Non-motor symptoms, particularly lower urinary tract symptoms (LUTS), significantly affect PD patients' quality of life.
- LUTS prevalence in PD ranges from 27% to 63.9% and is linked to disease stage and autonomic dysfunction.
Purpose of the Study:
- To review existing animal models of Parkinson's disease (PD) relevant to lower urinary tract dysfunction.
- To discuss the utility of these models in understanding PD-related urinary issues.
- To explore methods for selecting appropriate animal models for evaluating LUTS treatments in PD.
Main Methods:
- Literature review of animal models used in Parkinson's disease (PD) research.
- Analysis of how different PD models affect the autonomic nervous system.
- Discussion of techniques for assessing lower urinary tract (LUT) function in animal models.
Main Results:
- Animal models offer a platform for investigating PD-related dysfunction and testing treatments.
- Current animal research in PD has primarily focused on motor symptoms.
- The specific etiology of LUTS in PD remains unclear, necessitating further research using appropriate models.
Conclusions:
- Various animal models exist for PD, each impacting the autonomic nervous system differently.
- Understanding and selecting the right animal model is crucial for advancing research into LUTS treatments for Parkinson's disease.
- Further investigation into PD-specific animal models is needed to clarify the mechanisms of LUTS.
Related Concept Videos
Parkinson's Disease: Treatment
811
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
811
Parkinson's Disease: Overview
1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Neural Regulation
42.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.6K

